PharmaVision was created by Dr Cheryl Lee Barton in 2002 to provide high quality, due diligence research and independent, tailor made life science reports to pharmaceutical companies, competitive intelligence specialists, investment institutions and healthcare communication agencies. The research reports combine scientific analysis with market models to forecast the potential growth of key developmental products and technologies.
PharmaVision was formed in order to offer independent and impartial analysis of the life science industry with a focus on drug delivery and advanced technologies, key players and products, and to assess the challenges and opportunities which surround this specialist sector. Using PharmaVision's market modelling and in-depth interviews with key opinion leaders, we aim to deliver proactive research reports of high quality and value for our readers.